/
HCM
$12.16-$0.09 (-0.73%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$2.1B
174M shares
52-week range
$9.77 – $18.30
28% from low
Exchange
NASDAQ
ADRC
Change$-27.70
HUTCHMED (China) Limited American Depositary Shares
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
www.hutch-med.com- Employees
- 1,796
- IPO / List date
- Mar 17, 2016
Held by traders on TradeandTell
No one on the platform currently holds HCM.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 132,062 | $2.0M |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2009-04-20 | 1-for-50reverse |
Recent trades on TradeandTell
No one on the platform has traded HCM yet.
